HIIT vs Concurrent Training Battles Oxidative Stress in Postmenopausal Obese Women
A 12-week RCT compares HIIT and combined endurance-strength training on oxidative stress, inflammation, and cardiometabolic risk in obese postmenopausal women.
Summary
Menopause accelerates body composition changes and raises cardiometabolic risk partly through increased oxidative stress. This completed clinical trial enrolled 45 sedentary obese postmenopausal women and randomly assigned them to 12 weeks of high-intensity interval training, concurrent endurance plus strength training, or a control group. Both exercise protocols were performed three times per week, with HIIT alternating high- and low-intensity running intervals and concurrent training combining aerobic work with resistance exercises. The study measured body composition, cardiometabolic indices, and oxidative stress markers before and after the intervention. Results are not yet published, but the design directly addresses whether one exercise modality outperforms the other in reducing inflammation and metabolic dysfunction — a clinically meaningful question for millions of postmenopausal women seeking safe, effective, drug-free interventions.
Detailed Summary
Menopause is a major inflection point for women's cardiometabolic health. Declining estrogen disrupts fat distribution, raises blood pressure, worsens lipid profiles, and amplifies oxidative stress — a state in which reactive oxygen species outpace the body's antioxidant defenses. Chronic oxidative stress is now recognized as a driver of atherosclerosis, insulin resistance, and accelerated aging. Non-pharmacological strategies that durably reduce oxidative burden are therefore a high priority for researchers and clinicians alike.
This randomized controlled trial, sponsored by the University of Valladolid and registered as NCT07302191, enrolled 45 sedentary obese postmenopausal women and divided them into three groups: high-intensity interval training (HIIT), concurrent training (aerobic plus resistance), and a passive control. HIIT involved alternating 60-second bouts at 85–95% maximum heart rate with 60-second recovery intervals at 55–60% HRmax. Concurrent training paired aerobic work at 55–75% HRmax with two sets of resistance exercises at 55–75% of one-repetition maximum across eight stations. Both programs ran for 12 weeks, three sessions per week.
Primary outcomes included body composition, a panel of cardiometabolic indices, and biomarkers of oxidative stress and inflammation measured at baseline and after the 12-week program. The study is listed as completed with a December 2025 end date, though full results have not yet been peer-reviewed or published.
The clinical implications are significant. If HIIT proves superior, its time-efficiency makes it attractive for busy patients. If concurrent training performs better, its dual benefit of preserving muscle mass while improving aerobic capacity aligns well with the sarcopenia risk that accompanies menopause. Either finding will help clinicians tailor exercise prescriptions for this vulnerable population.
Caveats include a modest sample size of 45 (58 enrolled, suggesting dropout), an all-female postmenopausal cohort limiting generalizability, and the absence of published results — conclusions await peer review.
Key Findings
- Both HIIT and concurrent training were tested as 12-week, 3x/week interventions targeting oxidative stress in postmenopausal obese women.
- HIIT protocol used 85–95% HRmax intervals, pushing cardiovascular intensity well above typical moderate-exercise recommendations.
- Concurrent training combined aerobic and resistance work, addressing both cardiometabolic risk and muscle preservation simultaneously.
- Oxidative stress and cardiometabolic indices were primary endpoints, directly linking exercise type to biological aging mechanisms.
- Trial is completed; published results will clarify which modality best reduces inflammation and metabolic risk in this high-risk group.
Methodology
Randomized controlled trial with 45 sedentary obese postmenopausal women assigned to HIIT, concurrent endurance-plus-strength training, or a passive control group across 12 weeks. Outcomes included body composition, cardiometabolic biomarkers, and oxidative stress markers assessed at baseline and post-intervention. The original enrollment was 58 participants, indicating some dropout before final analysis.
Study Limitations
Summary is based on the abstract only; full results, effect sizes, and statistical analyses are not yet available as of this entry. The sample size of 45 (with 58 originally enrolled) is modest, and the all-postmenopausal obese female cohort limits generalizability to other populations. Absence of dietary control data and potential for performance bias in open-label exercise trials are additional considerations.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
